Wang G.X., Zhao X.Y., Meng Z.X., et al
Tirzepatide associated with greater weight loss in women than men All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this years Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept)
This hormone helps regulate blood sugar levels and induces a feeling of fullness, leading to reduced food intake
[14] [15] The relationship between diabetes and erectile function is multifactorial, involving vascular, neurological, hormonal, and psychological mechanisms that collectively impair the ability to achieve or maintain an erection sufficient for sexual activity